Eli Lilly and Company
Founded Year
1876Stage
IPO | IPODate of IPO
1/1/1952Market Cap
665.99BStock Price
727.21Revenue
$0000About Eli Lilly and Company
Eli Lilly and Company is a pharmaceutical company that develops medicines using biotechnology, chemistry, and genetic medicine. The company provides healthcare solutions that address health challenges. Eli Lilly and Company serves the healthcare sector with its medical products. It was founded in 1876 and is based in Indianapolis, Indiana.
Loading...
ESPs containing Eli Lilly and Company
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The D2C prescription weight loss & metabolic services market offers weight loss and metabolic management services directly to consumers, typically without the need for traditional healthcare provider involvement. These services often utilize digital platforms, telemedicine, and personalized approaches to provide convenient, accessible, and evidence-based solutions for individuals seeking to manage…
Eli Lilly and Company named as Highflier among 15 other companies, including Amazon, Novo Nordisk, and Omada Health.
Loading...
Research containing Eli Lilly and Company
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Eli Lilly and Company in 10 CB Insights research briefs, most recently on Jul 3, 2025.
May 23, 2025
The AI in drug R&D market map
Expert Collections containing Eli Lilly and Company
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eli Lilly and Company is included in 1 Expert Collection, including Fortune 500 Investor list.
Fortune 500 Investor list
590 items
This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.
Eli Lilly and Company Patents
Eli Lilly and Company has filed 1028 patents.
The 3 most popular patent topics include:
- medical equipment
- diabetes
- drug delivery devices
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/11/2023 | 4/8/2025 | Peptide hormones, Obesity, Potassium channel blockers, G protein coupled receptors, Diabetes | Grant |
Application Date | 10/11/2023 |
|---|---|
Grant Date | 4/8/2025 |
Title | |
Related Topics | Peptide hormones, Obesity, Potassium channel blockers, G protein coupled receptors, Diabetes |
Status | Grant |
Latest Eli Lilly and Company News
Sep 7, 2025
07.09.2025 - 10:27:04 Accelerated Pathway for Targeted Lung Cancer Treatment Eli Lilly has generated significant attention in oncology circles following the FDA’s decision to grant its lung cancer treatment Olomorasib the coveted Breakthrough Therapy designation. This regulatory milestone, announced Friday, positions the drug for an accelerated development and review pathway. Despite this achievement and management’s reaffirmation of 2025 financial guidance at the Wells Fargo Healthcare Conference, the company’s shares declined 2.2%, revealing a complex market dynamic. The Breakthrough Therapy designation represents a substantial regulatory achievement, reserved for medications demonstrating potential significant improvements over existing therapies. Olomorasib, intended for use in combination with Keytruda, is being developed as a first-line treatment for advanced non-small cell lung cancer patients possessing the specific KRAS G12C mutation.
Eli Lilly and Company Frequently Asked Questions (FAQ)
When was Eli Lilly and Company founded?
Eli Lilly and Company was founded in 1876.
Where is Eli Lilly and Company's headquarters?
Eli Lilly and Company's headquarters is located at Lilly Corporate Center, Indianapolis.
What is Eli Lilly and Company's latest funding round?
Eli Lilly and Company's latest funding round is IPO.
Who are Eli Lilly and Company's competitors?
Competitors of Eli Lilly and Company include Haleon, Roivant, CanSino Biologics, BeOne, Johnson & Johnson Innovative Medicine and 7 more.
Loading...
Compare Eli Lilly and Company to Competitors
Sumitomo Pharma is a biopharmaceutical company focused on developing therapeutic and scientific breakthroughs. The company's main offerings include the development of novel cancer therapeutics and a robust pipeline of treatments aimed at addressing unmet clinical needs in oncology. Sumitomo Pharma was formerly known as Sumitomo Dainippon Pharma. It was founded in 1897 and is based in Osaka, Japan.
Boehringer Ingelheim is involved in healthcare within the pharmaceutical and animal health sectors. The company conducts research and development of products for humans and animals. Boehringer Ingelheim serves the healthcare industry with an emphasis on pharmaceutical products. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.
LifeArc operates as a self-financing medical research charity. The organization specializes in drug discovery, diagnostics development, antibody humanization, and intellectual property management, aiming to lab-based scientific discoveries into diagnostics, treatments, and cures. LifeArc collaborates with various sectors including the pharmaceutical industry, biotechnology sector, and academic institutions to develop and commercialize medical research. LifeArc was formerly known as MRC Technology. It was founded in 2000 and is based in London, United Kingdom.
Taisho Pharmaceutical Holdings focuses on healthcare within the pharmaceutical industry. The company engages in the manufacturing and distribution of pharmaceutical products. It was founded in 1912 and is based in Tokyo, Japan.
SIIC Shanghai (Holdings) specializes in the production, wholesale, and retail of pharmaceuticals. The company is committed to providing medications and health-related products to meet the needs of both consumers and healthcare providers. SIIC Shanghai plays a vital role in improving access to quality medicines across various markets. It was founded in 1996 and is based in Shanghai, China.
Cerba HealthCare provides medical diagnostics within the healthcare sector. It offers diagnostic services including proximity biology, specialty biology, clinical trial biology, anatomical and cytological pathology, medical imaging, and preventive biology. These services are used for the diagnosis and management of diseases. It was founded in 1967 and is based in Issy-les-Moulineaux, France.
Loading...